{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:43:38Z","timestamp":1786221818198,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["H2024206010"],"award-info":[{"award-number":["H2024206010"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.brainres.2026.150469","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:53:27Z","timestamp":1784303607000},"page":"150469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic potential of pachymic acid in glioma: a comprehensive approach combining experimental validation, network pharmacology, and machine learning"],"prefix":"10.1016","volume":"1889","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2026.150469_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1255611","article-title":"Immunotherapy: a promising approach for glioma treatment","volume":"14","author":"Yasinjan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2026.150469_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.brainres.2026.150469_b0015","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.6004\/jnccn.2017.0166","article-title":"Holdhoff M et al: NCCN guidelines insights: central nervous system cancers, version 1.2017","volume":"15","author":"Nabors","year":"2017","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"12","key":"10.1016\/j.brainres.2026.150469_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/nu15122795","article-title":"Natural Products for the Immunotherapy of Glioma","volume":"15","author":"Huang","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.brainres.2026.150469_b0025","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/ptr.6426","article-title":"Prospect of natural products in glioma: a novel avenue in glioma management","volume":"33","author":"Kundu","year":"2019","journal-title":"Phytotherapy Research : PTR"},{"issue":"4","key":"10.1016\/j.brainres.2026.150469_b0030","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bbrc.2005.05.044","article-title":"Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos","volume":"332","author":"Gapter","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.brainres.2026.150469_b0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/mc.20487","article-title":"Polyporenic acid C induces caspase-8-mediated apoptosis in human lung cancer A549 cells","volume":"48","author":"Ling","year":"2009","journal-title":"Mol. Carcinog."},{"issue":"3","key":"10.1016\/j.brainres.2026.150469_b0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10549-010-0929-5","article-title":"Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-\u03baB-dependent matrix metalloproteinase-9 expression","volume":"126","author":"Ling","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.brainres.2026.150469_b0045","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.7314\/APJCP.2012.13.5.1877","article-title":"Inhibition of breast cancer metastasis via PITPNM3 by pachymic acid","volume":"13","author":"Hong","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.brainres.2026.150469_b0050","first-page":"2235","article-title":"Inhibition of ovarian cancer proliferation and invasion by pachymic acid","volume":"8","author":"Gao","year":"2015","journal-title":"Int. J. Clin. Exp. Path."},{"key":"10.1016\/j.brainres.2026.150469_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104787","article-title":"The PI3K\/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions","volume":"127","author":"Khezri","year":"2022","journal-title":"Exp. Mol. Pathol."},{"issue":"20","key":"10.1016\/j.brainres.2026.150469_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38800","article-title":"Pachymic acid promotes ferroptosis and inhibits gastric cancer progression by suppressing the PDGFRB-mediated PI3K\/Akt pathway","volume":"10","author":"Nie","year":"2024","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.brainres.2026.150469_b0065","first-page":"17781","article-title":"Pachymic acid inhibits tumorigenesis in gallbladder carcinoma cells","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.brainres.2026.150469_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2026.117518","article-title":"Antiproliferative effects of pachymic acid on thyroid cancer cells and characterization of its metabolites","volume":"277","author":"Wang","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.brainres.2026.150469_b0075","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad120","article-title":"Tahir Ul Qamar M: machine learning for synergistic network pharmacology: a comprehensive overview","volume":"24","author":"Noor","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"4","key":"10.1016\/j.brainres.2026.150469_b0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.14218\/FIM.2025.00043","article-title":"Insights into advantages and limitations of network pharmacology in traditional chinese medicine","volume":"4","author":"Zhao","year":"2025","journal-title":"Future Integr. Med."},{"issue":"3","key":"10.1016\/j.brainres.2026.150469_b0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.scib.2025.10.002","article-title":"POINT: a web-based platform for pharmacological investigation enhanced by multi-omics networks and knowledge graphs","volume":"71","author":"He","year":"2026","journal-title":"Sci. Bull."},{"key":"10.1016\/j.brainres.2026.150469_b0090","doi-asserted-by":"crossref","DOI":"10.4103\/NJPT.NJPT_57_25","article-title":"Network pharmacology: a systems-based paradigm for modern drug discovery","author":"Tejesh","year":"2025","journal-title":"Natl. J. Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2026.150469_b0095","doi-asserted-by":"crossref","unstructured":"Patne AY, Dhulipala SM, Lawless W, Prakash S, Mohapatra SS, Mohapatra S: Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches. In: International journal of molecular sciences. vol. 25; 2024: 12233.","DOI":"10.3390\/ijms252212233"},{"issue":"11","key":"10.1016\/j.brainres.2026.150469_b0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41573-023-00774-7","article-title":"Artificial intelligence for natural product drug discovery","volume":"22","author":"Mullowney","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"D1","key":"10.1016\/j.brainres.2026.150469_b0105","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.brainres.2026.150469_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminf."},{"issue":"W1","key":"10.1016\/j.brainres.2026.150469_b0115","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.brainres.2026.150469_b0120","doi-asserted-by":"crossref","unstructured":"Liu X, Ouyang S, Yu B, Liu Y, Huang K, Gong J, Zheng S, Li Z, Li H, Jiang H: PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res 2010, 38(Web Server issue):W609-614.","DOI":"10.1093\/nar\/gkq300"},{"issue":"6","key":"10.1016\/j.brainres.2026.150469_b0125","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acs.jcim.5b00690","article-title":"Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs","volume":"56","author":"Wang","year":"2016","journal-title":"J. Chem. Inf. Model."},{"issue":"W1","key":"10.1016\/j.brainres.2026.150469_b0130","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.brainres.2026.150469_b0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"D1","key":"10.1016\/j.brainres.2026.150469_b0140","doi-asserted-by":"crossref","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.brainres.2026.150469_b0145","series-title":"Practical Guide to Life Science Databases","first-page":"27","article-title":"The GeneCards Suite","author":"Safran","year":"2021"},{"issue":"D1","key":"10.1016\/j.brainres.2026.150469_b0150","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.brainres.2026.150469_b0155","doi-asserted-by":"crossref","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y et al: The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Current protocols in bioinformatics 2016, 54:1.30.31-31.30.33.","DOI":"10.1002\/cpbi.5"},{"issue":"D1","key":"10.1016\/j.brainres.2026.150469_b0160","doi-asserted-by":"crossref","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic target database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.brainres.2026.150469_b0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"Jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.brainres.2026.150469_b0170","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.brainres.2026.150469_b0175","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.brainres.2026.150469_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037297","article-title":"Human U87 astrocytoma cell invasion induced by interaction of \u03b2ig-h3 with integrin \u03b15\u03b21 involves calpain-2","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.brainres.2026.150469_b0185","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/glia.20825","article-title":"Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells","volume":"57","author":"Szeliga","year":"2009","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.brainres.2026.150469_b0190","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jnr.22794","article-title":"Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment","volume":"90","author":"Lal","year":"2012","journal-title":"J. Neurosci. Res."},{"issue":"12","key":"10.1016\/j.brainres.2026.150469_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082108","article-title":"Identification of novel genetic alterations in samples of malignant glioma patients","volume":"8","author":"Milinkovic","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2026.150469_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218211","article-title":"BTSCs exosomes derived NamiRNA-enhancer network of miR-151a-3p mediates a positive feedback loop and promotes the progression of glioma via FAK phosphorylation","volume":"639","author":"Qi","year":"2026","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.brainres.2026.150469_b0205","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.pharep.2019.03.006","article-title":"Citrus flavonoid 3,5,6,7,8,3',4'-heptamethoxyflavone induces BDNF via cAMP\/ERK\/CREB signaling and reduces phosphodiesterase activity in C6 cells","volume":"71","author":"Sawamoto","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.brainres.2026.150469_b0210","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1038\/srep05546","article-title":"Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule","volume":"4","author":"Kang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2026.150469_b0215","doi-asserted-by":"crossref","unstructured":"Ge X, Milenkovic L, Suyama K, Hartl T, Purzner T, Winans A, Meyer T, Scott MP: Phosphodiesterase 4D acts downstream of Neuropilin to control Hedgehog signal transduction and the growth of medulloblastoma. eLife 2015, 4.","DOI":"10.7554\/eLife.07068"},{"issue":"8\u20139","key":"10.1016\/j.brainres.2026.150469_b0220","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/carcin\/bgad041","article-title":"EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signaling","volume":"44","author":"Yu","year":"2023","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.brainres.2026.150469_b0225","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s42003-024-06118-4","article-title":"Co-clustering of EphB6 and ephrinB1 in trans restrains cancer cell invasion","volume":"7","author":"Liang","year":"2024","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/j.brainres.2026.150469_b0230","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1007\/s12013-024-01458-8","article-title":"Study on the Role of EPHB6 in Inhibiting the Malignant Progression of Cervical Cancer C33A Cells by Binding to CBX7","volume":"82","author":"Wang","year":"2024","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.brainres.2026.150469_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1175183","article-title":"Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer","volume":"13","author":"Jia","year":"2023","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.brainres.2026.150469_b0240","first-page":"1277","article-title":"Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients","volume":"19","author":"Jin","year":"2008","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.brainres.2026.150469_b0245","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1349-7006.2008.00866.x","article-title":"Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients","volume":"99","author":"Jin","year":"2008","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.brainres.2026.150469_b0250","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1471-4159.2007.05073.x","article-title":"5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid","volume":"104","author":"Massi","year":"2008","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.brainres.2026.150469_b0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.31083\/j.fbl2803063","article-title":"MAPK9 is correlated with a poor prognosis and tumor progression in glioma","volume":"28","author":"Yang","year":"2023","journal-title":"Front. Biosci."},{"issue":"44","key":"10.1016\/j.brainres.2026.150469_b0260","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1038\/onc.2011.634","article-title":"c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells","volume":"31","author":"Yoon","year":"2012","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.brainres.2026.150469_b0265","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41418-024-01360-z","article-title":"CCKBR+ cancer cells contribute to the intratumor heterogeneity of gastric cancer and confer sensitivity to FOXO inhibition","volume":"31","author":"Tan","year":"2024","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.brainres.2026.150469_b0270","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1568009622666220106113616","article-title":"Downregulation of CCKBR Expression inhibits the proliferation of gastric cancer cells, revealing a potential target for immunotoxin therapy","volume":"22","author":"Li","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.brainres.2026.150469_b0275","doi-asserted-by":"crossref","unstructured":"Ortega M, Agena E, Chen W, Cao H, Vasudevan S, Shivapurkar N, Pierobon M, Smith JP: Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In Vitro. International journal of molecular sciences 2025, 26(23).","DOI":"10.3390\/ijms262311699"},{"key":"10.1016\/j.brainres.2026.150469_b0280","doi-asserted-by":"crossref","unstructured":"Barzegar Behrooz A, Talaie Z, Jusheghani F, \u0141os MJ, Klonisch T, Ghavami S: Wnt and PI3K\/Akt\/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. International journal of molecular sciences 2022, 23(3).","DOI":"10.3390\/ijms23031353"},{"key":"10.1016\/j.brainres.2026.150469_b0285","article-title":"CAMK1D inhibits glioma through the PI3K\/AKT\/mTOR signaling pathway","volume":"12","author":"Jin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.brainres.2026.150469_b0290","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326003306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326003306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:10:16Z","timestamp":1786219816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899326003306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"alternative-id":["S0006899326003306"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150469","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of pachymic acid in glioma: a comprehensive approach combining experimental validation, network pharmacology, and machine learning","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150469"}}